“LL-37”的搜索结果，显示 231-240 项，共有 6951 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

3. 肾病和高血压- 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44 · NextNext Page. 以下为当前的临床试验。 37 研究肾病和高血压（仅限开放性研究）. 按位置、状态和其他条件筛选该研究 ...

4. 血液科- 临床试验- 妙佑医疗国际

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 study in a selected cohort of patient with LM. Prehabilitation. Rochester, Minn. Physical activity plays an important role in reducing the adverse effects ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

7. 血液科- 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone ... The study has 2 Modules: Module 1 for FL and Module 2 for DLBCL. Pagination ...

8. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

9. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...